Dow Up 0.51% Nasdaq Up 0.24%

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioLineRx, Ltd. (BLRX)

-NasdaqCM
1.27 Down 0.01(0.79%) Nov 21, 3:59PM EST
Prev Close:1.28
Open:1.30
Bid:1.22 x 100
Ask:N/A
1y Target Est:7.33
Beta:2.14
Next Earnings Date:N/A
Day's Range:1.25 - 1.34
52wk Range:1.23 - 3.34
Volume:57,220
Avg Vol (3m):75,839
Market Cap:43.33M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BLRX

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback